New cholesterol combo pill aims to slash bad cholesterol without prior meds
NCT ID NCT07619131
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new pill that combines two drugs (laroprovstat and rosuvastatin) to lower LDL or 'bad' cholesterol. About 600 adults with high cholesterol who have never taken cholesterol-lowering medication will receive either the combination, one of the drugs alone, or a placebo. The main goal is to see how much LDL drops after 8 weeks and to check for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo pill aims to supercharge cholesterol lowering
- New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
- One shot to tackle two heart risks? new combo drug enters human trials
- Are cholesterol patients getting the right care? new study aims to find out
- Plant power: natural extract shows promise for high cholesterol
- Could a probiotic be the next Heart-Healthy superfood?